Fund Holdings — TCG Crossover Management, LLC

Total Portfolio Value:
$4.16B
Total Bought:
$482.74M
Total Sold:
$465.04M
Net Transaction:
+$17.69M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
ABIVAX Société AnonymeCOMM(ABVX)6,481,0856,007,834-473,251$721.67M$800.60M19.24%+$78.94M
Tango Therapeutics, Inc.COMM(TNGX)10,531,0719,081,201-1,449,870$220.31M$283.88M6.82%+$63.57M
CG Oncology, Inc.COMM(CGON)3,670,2063,670,2060$248.40M$260.77M6.27%+$12.37M
Cogent Biosciences, Inc.COMM(COGT)4,946,8944,854,436-92,458$190.41M$187.87M4.52%-$2.54M
Immunovant, Inc.COMM(IMVT)4,457,9884,457,9880$110.74M$171.77M4.13%+$61.03M
Spyre Therapeutics, Inc.COMM(SYRE)1,900,5821,900,5820$95.87M$168.73M4.06%+$72.87M
Dianthus Therapeutics, Inc.COMM(DNTH)1,676,6241,676,6240$140.70M$163.44M3.93%+$22.74M
Mirum Pharmaceuticals, Inc.COMM(MIRM)1,062,0491,062,0490$98.11M$124.33M2.99%+$26.22M
Zai Lab LimitedADRS(ZLAB)06,137,627+6,137,627$0$116.61M2.80%+$116.61M
Amylyx Pharmaceuticals, Inc.COMM(AMLX)6,243,8126,243,8120$86.79M$112.14M2.70%+$25.35M
Monte Rosa Therapeutics, Inc.COMM(GLUE)4,622,1514,622,1510$76.03M$111.86M2.69%+$35.82M
BioCryst Pharmaceuticals, Inc.COMM(BCRX)11,020,96811,020,9680$104.92M$110.21M2.65%+$5.29M
Vor Biopharma Inc.COMM(VOR)5,673,0785,673,0780$96.50M$104.44M2.51%+$7.94M
Tyra Biosciences, Inc.COMM(TYRA)3,248,9803,248,9800$124.44M$103.77M2.49%-$20.66M
Dyne Therapeutics, Inc.COMM(DYN)4,615,1444,615,1440$83.67M$102.50M2.46%+$18.83M
Disc Medicine, Inc.COMM(IRON)1,341,8621,341,8620$85.80M$98.14M2.36%+$12.35M
Relay Therapeutics, Inc.COMM(RLAY)4,273,3564,273,3560$42.52M$79.95M1.92%+$37.43M
Savara Inc.COMM(SVRA)12,362,20512,362,2050$67.50M$76.15M1.83%+$8.65M
Aura Biosciences, Inc.COMM(AURA)09,533,333+9,533,333$0$67.69M1.63%+$67.69M
Revolution Medicines, Inc.COMM(RVMD)576,473340,899-235,574$56.06M$63.84M1.53%+$7.78M
First Tracks BiotherapeuticsCOMM02,895,304+2,895,304$0$58.25M1.40%+$58.25M
Kodiak Sciences Inc.COMM(KOD)1,445,5381,445,5380$55.10M$56.32M1.35%+$1.21M
Avalo Therapeutics, Inc.COMM(AVTX)738,3833,017,120+2,278,737$11.02M$55.76M1.34%+$44.73M
LB Pharmaceuticals IncCOMM(LBRX)1,839,4891,447,310-392,179$45.28M$46.97M1.13%+$1.69M
Century Therapeutics, Inc.COMM(IPSC)17,754,43017,754,4300$39.02M$43.40M1.04%+$4.38M
Tectonic Therapeutic, Inc.COMM(TECX)1,204,8911,204,8910$37.24M$41.42M1.00%+$4.17M
Xencor, Inc.COMM(XNCR)2,452,1382,452,1380$29.57M$39.48M0.95%+$9.91M
Surrozen, Inc.COMM(SRZN)1,473,1011,473,1010$42.91M$38.23M0.92%-$4.68M
Editas Medicine, Inc.COMM(EDIT)011,111,111+11,111,111$0$36.00M0.87%+$36.00M
MBX Biosciences, Inc.COMM(MBX)650,000650,0000$19.40M$35.88M0.86%+$16.48M
Pharvaris BvCOMM
COM
01,008,229+1,008,229$0$34.86M0.84%+$34.86M
Silence Therapeutics plcADRS(SLN)3,033,5603,033,5600$15.99M$33.31M0.80%+$17.32M
InflaRx N.V.COMM(IFRX)014,500,000+14,500,000$0$32.48M0.78%+$32.48M
Altimmune, Inc.COMM(ALT)010,000,000+10,000,000$0$30.40M0.73%+$30.40M
Janux Therapeutics, Inc.COMM(JANX)1,789,6171,789,6170$24.88M$27.49M0.66%+$2.61M
Perspective Therapeutics, Inc.COMM(CATX)7,915,5677,915,5670$33.01M$26.99M0.65%-$6.02M
AgomAb Therapeutics NVADRS(AGMB)2,053,2332,053,2330$21.54M$26.65M0.64%+$5.11M
Biohaven Ltd.COMM(BHVN)4,631,3171,779,952-2,851,365$39.18M$26.49M0.64%-$12.70M
Aktis Oncology, Inc.COMM(AKTS)0696,560+696,560$0$22.45M0.54%+$22.45M
Alector IncCOMM10,000,00010,000,0000$21.50M$20.10M0.48%-$1.40M
Forte Biosciences IncCOMM0920,000+920,000$0$19.55M0.47%+$19.55M
Monopar Therapeutics Inc.COMM(MNPR)132,103203,327+71,224$7.24M$18.83M0.45%+$11.59M
Ocular Therapeutix, Inc.COMM(OCUL)1,647,7521,647,7520$13.96M$16.18M0.39%+$2.22M
ADC Therapeutics SACOMM(ADCT)11,390,17511,390,1750$42.71M$12.19M0.29%-$30.53M
ALX Oncology Holdings Inc.COMM(ALXO)13,011,8495,655,487-7,356,362$26.09M$11.71M0.28%-$14.38M
Entrada Therapeutics, Inc.COMM(TRDA)2,287,5001,060,230-1,227,270$28.87M$7.80M0.19%-$21.06M
Cullinan Therapeutics, Inc.COMM(CGEM)406,786406,7860$5.78M$7.41M0.18%+$1.63M
Arvinas, Inc.COMM(ARVN)2,387,461707,098-1,680,363$25.31M$5.88M0.14%-$19.43M
Korro Bio, Inc.COMM(KRRO)416,301416,3010$4.71M$5.49M0.13%+$774.3K
Research Alliance Corp Cl ACOMM0500,000+500,000$0$5.35M0.13%+$5.35M
LeonaBio, Inc.COMM(LONA)464,398464,3980$4.67M$4.27M0.10%-$398.8K
Jatt Ii Acquisition CorpCOMM0200,000+200,000$0$2.27M0.05%+$2.27M
Context Therapeutics Inc.COMM(CNTX)2,682,6962,682,6960$7.03M$1.49M0.04%-$5.54M
Eikon Therapeutics, Inc.COMM(EIKN)037,902+37,902$0$494.6K0.01%+$494.6K
Centessa Pharmaceuticals PlcADRS4,286,4800-4,286,480$170.26M$0—-$170.26M
Fulcrum Therapeutics, Inc.COMM(FULC)5,250,0000-5,250,000$40.27M$0—-$40.27M
Liquidia CorporationCOMM(LQDA)403,0480-403,048$15.21M$0—-$15.21M
Structure Therapeutics IncADRS140,4110-140,411$6.77M$0—-$6.77M
Upstream Bio, Inc.COMM(UPB)181,0630-181,063$1.63M$0—-$1.63M
UroGen Pharma Ltd.COMM(URGN)405,3650-405,365$7.29M$0—-$7.29M
Vistagen Therapeutics, Inc.COMM(VTGN)2,676,5800-2,676,580$1.53M$0—-$1.53M
Page 1 of 1